(Q38112887)

29 August 2017

title

Challenges in the management of acute peptic ulcer bleeding (English)

1 reference

29 August 2017

4

Ernst J Kuipers

1 reference

29 August 2017

James Y W Lau

1

1 reference

29 August 2017

Alan Barkun

2

1 reference

29 August 2017

Dai-ming Fan

3

1 reference

29 August 2017

Yun-sheng Yang

5

1 reference

29 August 2017

Francis K L Chan

6

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 June 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

381

1 reference

29 August 2017

issue

9882

1 reference

29 August 2017

page(s)

2033-2043

1 reference

Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Epidemiology of peptic ulcer disease in Wuhan area of China from 1997 to 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Time-trends in the epidemiology of peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Bleeding peptic ulcer - time trends in incidence, treatment and mortality in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Changing trends in acute upper-GI bleeding: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Predictive factors of mortality from nonvariceal upper gastrointestinal hemorrhage: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Transfusion strategies for acute upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Impact of anticoagulation on rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Does this patient have a severe upper gastrointestinal bleed?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Risk assessment after acute upper gastrointestinal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

A risk score to predict need for treatment for upper-gastrointestinal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Multicentre comparison of the Glasgow Blatchford and Rockall Scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Prokinetics in acute upper GI bleeding: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Endoscopy for acute nonvariceal upper gastrointestinal tract hemorrhage: is sooner better? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Early or delayed endoscopy for patients with peptic ulcer bleeding. A prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Urgent vs. elective endoscopy for acute non-variceal upper-GI bleeding: an effectiveness study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Proton pump inhibitor treatment for acute peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

National audit of the use of surgery and radiological embolization after failed endoscopic haemostasis for non-variceal upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Role of transcatheter arterial embolization for massive bleeding from gastroduodenal ulcers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Transcatheter arterial embolization versus surgery in the treatment of upper gastrointestinal bleeding after therapeutic endoscopy failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Transcatheter arterial embolization in the management of bleeding duodenal ulcers: a 5.5-year retrospective study of treatment and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Is transcatheter arterial embolization a safer alternative than surgery when endoscopic therapy fails in bleeding duodenal ulcer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

A comparison of angiographic embolization with surgery after failed endoscopic hemostasis to bleeding peptic ulcers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

A comparison of surgery versus transcatheter angiographic embolization in the treatment of nonvariceal upper gastrointestinal bleeding uncontrolled by endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Managing acute upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Clopidogrel with or without omeprazole in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

Tranexamic acid for upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960596-6

7 January 2021

10.1016/S0140-6736(13)60596-6

Identifiers

DOI

1 reference

release_hkbxmpveorcsjmmffk563y5doi

29 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hkbxmpveorcsjmmffk563y5doi

24 November 2022

mapped directly with Wikidata item

1 reference